precision plus protein dualcolor ladder (Bio-Rad)
Bio-Rad is a verified supplier 
97
Structured Review
Bio-Rad
precision plus protein dualcolor ladder
Precision Plus Protein Dualcolor Ladder, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 97/100, based on 3014 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/protein+ladder+dualcolor/Precision+Plus+Protein+Dual+Color+Standards/pm40200337-137-11-16
Average 97 stars, based on 3014 article reviews
Precision Plus Protein Dualcolor Ladder, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 97/100, based on 3014 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/protein+ladder+dualcolor/Precision+Plus+Protein+Dual+Color+Standards/pm40200337-137-11-16
Average 97 stars, based on 3014 article reviews
precision plus protein dualcolor ladder - by Bioz Stars,
2026-09
97/100 stars
Images
Related Articles
Staining:Article Title: On the adjuvanticity of hyaluronan: The case of a SARS-CoV-2 vaccine. Article Snippet: Vaccines based on mRNA have been fundamental in facing the COVID-19 pandemic, however, they still raise concerns about stability and long-term efficacy.. Thus, protein-based vaccines remain valid options and hence the study of effective adjuvants is crucial.. Here, we developed a COVID-19 vaccine based on the receptor-binding domain (RBD) of SARS-CoV-2 Spike protein, which is covalently conjugated to the natural polymer hyaluronan (HA) that acts as an immunological adjuvant. Negative Control:Article Title: On the adjuvanticity of hyaluronan: The case of a SARS-CoV-2 vaccine. Article Snippet: Vaccines based on mRNA have been fundamental in facing the COVID-19 pandemic, however, they still raise concerns about stability and long-term efficacy.. Thus, protein-based vaccines remain valid options and hence the study of effective adjuvants is crucial.. Here, we developed a COVID-19 vaccine based on the receptor-binding domain (RBD) of SARS-CoV-2 Spike protein, which is covalently conjugated to the natural polymer hyaluronan (HA) that acts as an immunological adjuvant. Positive Control:Article Title: On the adjuvanticity of hyaluronan: The case of a SARS-CoV-2 vaccine. Article Snippet: Vaccines based on mRNA have been fundamental in facing the COVID-19 pandemic, however, they still raise concerns about stability and long-term efficacy.. Thus, protein-based vaccines remain valid options and hence the study of effective adjuvants is crucial.. Here, we developed a COVID-19 vaccine based on the receptor-binding domain (RBD) of SARS-CoV-2 Spike protein, which is covalently conjugated to the natural polymer hyaluronan (HA) that acts as an immunological adjuvant. |